Partners4Access is pleased to announce the addition of Rosa Pandolfo to the London office

Continued focus is ‘Orphan Drug Solutions’ a partnership approach to ensuring a successful global launch. Partners4Access, the global access experts for orphan drugs, is pleased to announce that Rosa Pandolfo joined the company’s London Office as Senior Consultant. This addition helps further secure P4A’s position as the go-to partner for orphan drug manufacturers. Schmitz, Managing…

Partners4Access collaborates with Cambridge University

          Partners4Access, the global access experts for orphan drugs, has entered into a collaboration with Cambridge University to support their Graduate Professional Practice Programme.  Partners4Access will support a student from the Masters in Bioscience Enterprise program develop their dissertation, providing a platform to engage in a corporate-level environment.  Sophie Schmitz, Managing Partner at Partners4Access said,…

Partners4Access represented at ISPOR

Partners4Access was part of this year’s ISPOR conference in Vienna where payers, manufacturers, regulators and politicians met. High profile speakers from national, regional and global bodies discussed different pricing models for pharmaceuticals, their feasibility and importance to create sustainable and fair health systems. Striving towards a fair health system is closely linked to another key…

Partners4Access is pleased to announce the addition of Jose Luis Betrian to the executive team

Executive team strengthened to drive further launch support for the biotechnology industry. Continued focus is ‘Orphan Drug Solutions’ a partnership approach to ensuring a successful global launch. Partners4Access, the global access experts for orphan drugs, has strengthened its executive team this week with the addition of Jose Luis Betrian. Jose Luis joins as Executive Director,…